Quality of life (QOL) in patients with multiple sclerosis (MS) is influenced by disease progression and the level of disability, as well as individ......READ MORE
As the probability of active multiple sclerosis (MS) declines with age and the susceptibility to adverse effects increases, the risks vs the benefi......READ MORE
Consistent progress has been made in the identification of pharmacogenomic markers of disease-modifying therapy response in multiple sclerosis (MS)......READ MORE
The interaction between sex hormones and inflammation is a potentially important factor in the occurrence of relapses in women with multiple sclero......READ MORE
Timely, scientific, professional communication about multiple sclerosis (MS) remains a growing need. Many organizations, such as the Consortium of ......READ MORE